Dr. Reddys Unveils Drug-Free Migraine Management Device in Europe
Dr. Reddy’s Laboratories Ltd. has introduced the non-invasive migraine management wearable device, Nerivio in Germany through its step-down subsidiary Betapharm.
Global Pharma | 11/04/2024 | By Aishwarya | 1167
Sanofi Receives Nod for IMOVAX-Polio in India
Sanofi has gained approval for IMOVAX-Polio, an alternative injectable vaccine.
Global Pharma | 11/04/2024 | By Aishwarya | 641
Aptar Pharma Gets NMPA Nod for Airless Drug Delivery System
Aptar Pharma has received approval by the National Medical Products Administration (NMPA) in China of Sinomune Pharmaceutical’s Li Fu metronidazole gel.
Global Pharma | 11/04/2024 | By Aishwarya | 825
Strides Pharma Receives FDA Approval for Antidepressant Drug
Strides Pharma Science’s subsidiary has gained approval from the US health regulator to market a generic antidepressant medication.
Global Pharma | 10/04/2024 | By Aishwarya | 1148
MOLLI Surgical Introduces OncoPen: A Revolutionary Tool in Breast Cancer Surgery
This sleek, pen-like wand seamlessly integrates with the acclaimed MOLLI® 2 System, providing sophisticated tools for precisely targeting and removing cancerous lesions.
Global Pharma | 10/04/2024 | By Abha | 682
This heart arrhythmia, affecting millions worldwide, has seen a revolutionary approach after receiving approval from the US Food and Drug Administration.
Global Pharma | 10/04/2024 | By Abha | 445
Nvelop Therapeutics to Launch Dual Platforms for In Vivo Delivery of Next-Gen of Genetic Medicines
Nvelop Therapeutics has officially announced to develop the next generation of genetic medicines for a wide range of diseases.
Global Pharma | 10/04/2024 | By Aishwarya | 680
Invenra Signs Research Deal with Astellas Pharma to Boost Bispecific Therapeutic Research
Invenra Inc. has forged a strategic research agreement with Astellas Pharma, a global pharmaceutical company with a vision to turn innovative science into value for patients.
Global Pharma | 10/04/2024 | By Aishwarya | 697
As part of the collaboration, Bayer will further develop its innovation platform to accelerate the development and deployment of AI-powered healthcare applications with a clear focus on radiology, using Google Cloud's technology, including its generative AI (gen AI) tools.
Global Pharma | 09/04/2024 | By Manvi | 595
FDA Grants Seven-Year Exclusivity to RADICAVA ORS for ALS Treatment
This recognition highlights the FDA's acknowledgment of the oral form of edaravone as a crucial advancement for ALS patients, providing a more accessible treatment option.
Global Pharma | 09/04/2024 | By Abha | 1346
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy